Diagnostic markers of endometrial cancer

Developed by: Fundació Hospital Universitari Vall d’Hebron - Institut de Recerca


The present invention (CEMARK) describes a set of robust protein biomarkers in uterine fluid samples to diagnose and preoperatively stage EC, in a more efficient and accurate manner compared to current diagnostic methods.

CEMARK will be introduced as an easy, quick and less costly diagnostic kit. Its implementation in a routine basis will prevent overdiagnosis (no need to perform invasive biopsies).

Stage of development: TRL 4, biomarkers validated in the lab.

IP: Priority EP Patent filed.

Health technology: